Evidence map›Paper›PMID 37323489›Full record

ReviewInternational journal of bioprinting2023

Evolution of bioprinting and current applications.

Laura Mendoza-Cerezo, M Rodríguez-Rego Jesús, Antonio Macías-García, Alfonso C Marcos-Romero, Antonio Díaz-Parralejo

Abstract readReview
In one paragraph

Review in International journal of bioprinting, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura Mendoza-CerezoDepartamento de Expresión Gráfica, Escuela de Ingenierías Industriales, Universidad de Extremadura, Avenida de Elvas, s/n. 06006-Badajoz, Spain.
M Rodríguez-Rego JesúsDepartamento de Expresión Gráfica, Escuela de Ingenierías Industriales, Universidad de Extremadura, Avenida de Elvas, s/n. 06006-Badajoz, Spain.
Antonio Macías-GarcíaDepartamento de Ingeniería Mecánica, Energética y de los Materiales, Escuela de Ingenierías Industriales, Universidad de Extremadura, Avenida de Elvas, s/n. 06006-Badajoz, Spain.
Alfonso C Marcos-RomeroDepartamento de Expresión Gráfica, Escuela de Ingenierías Industriales, Universidad de Extremadura, Avenida de Elvas, s/n. 06006-Badajoz, Spain.
Antonio Díaz-ParralejoDepartamento de Ingeniería Mecánica, Energética y de los Materiales, Escuela de Ingenierías Industriales, Universidad de Extremadura, Avenida de Elvas, s/n. 06006-Badajoz, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioprinting is a very useful tool that has a huge application potential in different fields of science and biotechnology. In medicine, advances in bioprinting are focused on the printing of cells and tissues for skin regeneration and the manufacture of viable human organs, such as hearts, kidneys, and bones. This review provides a chronological overview of some of the most relevant developments of bioprinting technique and its current status. A search was carried out in SCOPUS, Web of Science, and PubMed databases, and a total of 31,603 papers were found, of which 122 were finally chosen for analysis. These articles cover the most important advances in this technique at the medical level, its applications, and current possibilities. Finally, the paper ends with conclusions about the use of bioprinting and our expectations of this technique. This paper presents a review on the tremendous progress of bioprinting from 1998 to the present day, with many promising results indicating that our society is getting closer to achieving the total reconstruction of damaged tissues and organs and thus solving many healthcare-related problems, including the shortage of organ and tissue donors.

Indexed as

3D printingBioprintingOrgan cultureTissue engineeringTissue regeneration

Identifiers

PMID37323489
PMCPMC10261138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.